文献速递疝与腹壁外科

PGA-TMC可吸收合成支架在清洁与污染腹壁疝修补术中的长期结局

Long-term outcomes of PGA-TMC absorbable synthetic scaffold in both clean and contaminated ventral hernia repairs.
PubMed 文献 · Surg Endosc · 2024-03-18

本研究回顾性分析了2008年10月至2018年6月使用GORE BIO-A(BIO-A)辅助腹壁重建的207例腹壁疝修补患者,评估其安全性和长期结局。总体复发率为17.4%,污染病例复发率28.8%高于清洁病例10.4%(p=0.002)。作者认为生物合成补片在所有伤口分类中均为成本有效的替代选择,结局良好、长期并发症有限且复发率低。

要点

  • 总体复发率17.4%,污染病例复发率28.8% vs 清洁病例10.4%(p=0.002)。
  • 复发患者BMI更高(32.4 vs 28.4 kg/m2,p=0.0011),住院时间更长(11.1 vs 5.6天,p=0.0051)。
  • 30天总并发症率24.5%,包括手术部位感染等。

核心结论

  • 本研究证实生物合成补片在所有伤口分类中均可作为成本有效的替代选择,结局良好、长期并发症有限且复发率低。

研究设计与样本

  • 回顾性综述,纳入2008年10月至2018年6月期间使用BIO-A进行腹壁疝修补的患者,共207例。

主要发现

  • CDC伤口分类I、II、III、IV类分别为127例(61.4%)、41例(19.8%)、14例(6.8%)、25例(12.1%)。
  • 中位随访55.4个月(范围0.2-162.4),总体复发率17.4%。
  • 污染病例复发率28.8% vs 清洁病例10.4%(p=0.002),平均随访时间分别为46.9个月和60.8个月。
  • 复发患者BMI为32.4 vs 非复发患者28.4 kg/m2(p=0.0011),疝面积为162.2 vs 106.7 cm2(p=0.10),住院时间为11.1 vs 5.6天(p=0.0051),重返手术/操作室率为16.7% vs 5.6%(p=0.053)。
  • 51例(24.5%)发生并发症,包括19例(9.2%)手术部位事件、7例(3.4%)表浅手术部位感染、16例(7.7%)深部手术部位感染和1例(0.5%)器官腔隙感染。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biosynthetic meshes afford the cost advantages of being made from fully synthetic material, but are also biodegradable, making them a versatile option that can be used in both clean and contaminated cases. The aim of this study is to evaluate the safety profile and long-term outcomes of using GORE BIO-A (BIO-A) as an adjunct to abdominal wall reconstruction in all wound classes. METHODS: A retrospective review identified patients undergoing abdominal hernia repair using BIO-A from October 2008 to June 2018. The primary outcome was hernia recurrence rate. Only patients with at least 6-month follow-up were included when looking at recurrence rates. Secondary outcomes included 30-day morbidity categorized according to CDC Surgical Site Infection Criteria, return to operating/procedure room (RTOR), 30-day readmission, length of stay (LOS), and mortality. RESULTS: A total of 207 patients were identified, CDC Wound Classification breakdown was 127 (61.4%), 41 (19.8%), 14 (6.8%), and 25 (12.1%) for wound classes I, II, III, and IV, respectively. Median follow-up was 55.4 months (range 0.2-162.4). Overall recurrence rate was 17.4%. Contaminated cases experienced higher recurrence rates (28.8% versus 10.4%, p = 0.002) at a mean follow up of 46.9 and 60.8 months for contaminated and clean patients, respectively. Recurrent patients had higher BMI (32.4 versus 28.4 kg/m2, p = 0.0011), larger hernias (162.2 versus 106.7 cm2, p = 0.10), higher LOS (11.1 versus 5.6 days, p = 0.0051), and higher RTOR rates (16.7% versus 5.6%, p = 0.053). 51 (24.5%) patients experienced some morbidity, including 19 (9.2%) surgical site occurences, 7 (3.4%) superficial surgical site infections, 16 (7.7%) deep surgical site infections, and 1 (0.5%) organ space infection. CONCLUSION: This study affirms the use of biosynthetic mesh as a cost-effective alternative in all wound classifications, yielding good outcomes, limited long-term complications, and low recurrence. rates.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Huang EY, Broderick RC, Spurzem GJ, et al. Long-term outcomes of PGA-TMC absorbable synthetic scaffold in both clean and contaminated ventral hernia repairs. Surg Endosc. 2024. PMID: 38498213. doi:10.1007/s00464-024-10777-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。